Dr Reddy’s

DR won’t be able to promote weight reduction medicine in India Reddy’s and Onesource, Delhi Excessive Court docket stayed as a consequence of patent dispute

by
DR won’t be able to promote weight reduction medicine in India Reddy’s and Onesource, Delhi Excessive Court docket stayed as a consequence of patent dispute

Semaglutide Patent Dispute: Delhi Excessive Court docket has issued an vital interim order within the patent dispute associated to Denmark’s drug firm Novo Nordisk’s well-known anti-dibitic and anti-obesity drug semaglutide. Court docket did Dr. Reddy’s Laboratories and Onesource Specialty Pharma have been stopped from gross sales and advertising of this drug in India. Nonetheless, they’re … Read more

Shares to observe: Regulate these 14 shares on Monday, you may get an opportunity to earn robust earnings

by
Shares to observe: Regulate these 14 shares on Monday, you may get an opportunity to earn robust earnings

Shares to Watch: On Monday (Might 12) within the inventory market, motion may be seen within the shares of many massive firms. Some firms have launched implausible quarterly outcomes, whereas some have confronted losses. On the identical time, some companies have additionally been knowledgeable about main modifications or new contracts. In such a state of … Read more

Dr Reddy’s cheaper option will give strong profit, Ashish Baheti’s 3 F&O calls will be made big money

by
Dr Reddy’s cheaper option will give strong profit, Ashish Baheti’s 3 F&O calls will be made big money

Top F & O Calls: Market is currently trading up. The Nifty saw a gain of about 56 points and the Sensex got a strength of about 164 points. Talking about F&O, shares of Britannia, Wipro, CDSL, Tube Investments, Dabur, IOC, BPCL, Colgate were seen in the red mark. On the other hand, MCX, Muthoot … Read more